N/A N=63 Randomized Single-blind Supportive Care

Care to Plan: a Tailored Resource for Family Members of Persons With Dementia

Dementia · Alzheimer Disease · Memory Loss

Bottom Line

View on ClinicalTrials.gov: NCT03901456 ↗

Enrolled (actual)

Serious AEs

1.6%

Results posted

Jun 2023

Primary outcome: Primary: Caregiver Self-efficacy — 3.62; 3.36; 3.84; 3.57 scores on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Care to Plan (Behavioral); Usual Care (Behavioral)
Age: Adult, Older Adult · 21+ yrs
Sex: All
Sponsor: University of Minnesota
Primary completion: May 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY Caregiver Self-efficacy	3.62; 3.36; 3.84; 3.57; 3.58; 3.55	—
SECONDARY Care to Plan Service Use	2.69; 2.62; 3.00; 2.56; 2.31; 2.25	—
SECONDARY Phase II - Caregiver Distress: Role Overload	3.23; 3.71; 3.18; 3.56; 3.15; 3.77	—
SECONDARY Primary Subjective Stressors: Loss of Intimate Exchange	3.30; 2.86; 3.25; 2.98; 3.35; 3.13	—
SECONDARY Caregiver Distress: Role Captivity	1.97; 2.27; 1.98; 2.17; 1.94; 2.29	—
SECONDARY Center for Epidemiological Studies Depression (CES-D)	15.73; 19.10; 18.47; 21.50; 18.19; 20.50	—

Summary

The present study will refine and conduct a preliminary efficacy evaluation of Care to Plan. Care to Plan is an online care planning tool that provides a succinct and clear overview of various types of dementia caregiver interventions, administers a brief validated assessment of risk, and generates individualized recommendations for dementia caregivers as well as resources that link users to a selected recommendation. There remains a lack of individualized information that can directly meet the diverse needs of caregivers or their relatives with Alzheimer's disease or a related dementia (ADRD). This project will advance scientific knowledge, technical capability, and clinical practice as they pertain to ADRD management and caregiver support.

Eligibility Criteria

Inclusion Criteria: The care recipient has received a provider diagnosis of Alzheimer's disease or a related dementia (ADRD); and 2) the caregiver is 21 years of age or older; 3) English-speaking; 4) self-identifies as someone who provides help to the person with ADRD because of their cognitive impairments; 5) the caregiver indicates a willingness to use Care to Plan (CtP); and 6) caregiver resides in one of 4 Riverside Health regions (based on zip code). Exclusion Criteria: Those who do not meet the inclusion criteria above are not eligible. Additionally, those who endorse a history of a serious mental health disorder whose: a) symptoms have exacerbated in the last six months, and b) are not receiving steady, ongoing pharmacological or other treatment for these symptoms, will be excluded from the project.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03901456). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.